SLCA Earnings

SLCA reported its earnings on 2024-08-01, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.25 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SLCA's earnings announcement on 2024-08-01, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, SLCA's stock price tends to shift by an average of 0% in the 10 days leading up to earnings and 0% in the 10 days following, providing insight into potential market.

For , analysts estimate SLCA's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SLCA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SLCA's stock price typically moves by 0% in the 10 days before its earnings and 0% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call presents strong financial metrics, with significant year-over-year growth in net income and EBITDA. Despite a sequential revenue decline, optimistic guidance for 2024 in the ISP segment and strategic debt reduction indicate positive future prospects. The Q&A highlights stability in pricing and strategic capital allocation, reinforcing a favorable outlook. Given the mid-sized market cap, the stock is likely to react positively, with an expected price increase of 2% to 8% over the next two weeks.